2021
DOI: 10.1007/s11255-021-02973-w
|View full text |Cite
|
Sign up to set email alerts
|

Cytomegalovirus infection in patients with glomerular diseases treated with cyclophosphamide: a single-center prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Hence, prophylactic therapy might be considered. A single-center prospective study in Turkey proposed a cut-off of 500 copies of CMV DNA per ml to treat CMV infection and improve outcomes in glomerulonephritis patients [ 101 ]. Furthermore, a risk stratification algorithm was proposed by Lim et al to decide who deserved antiviral agents among patients with GN with positive CMV [ 102 ].…”
Section: Immunosuppressive Treatment and Infectionmentioning
confidence: 99%
“…Hence, prophylactic therapy might be considered. A single-center prospective study in Turkey proposed a cut-off of 500 copies of CMV DNA per ml to treat CMV infection and improve outcomes in glomerulonephritis patients [ 101 ]. Furthermore, a risk stratification algorithm was proposed by Lim et al to decide who deserved antiviral agents among patients with GN with positive CMV [ 102 ].…”
Section: Immunosuppressive Treatment and Infectionmentioning
confidence: 99%